Retatrutide, developed by Soma Pharmaceuticals , represents a significant advance in body regulation. This unique compound combines hormonal receptor properties with another receptor engagement, showing substantial potential in patient studies for metabolic improvement. Scientists believe this treatment may offer a new solution for individuals stru